Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Terence Flynn is an analyst at Morgan Stanley. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/05/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/05/2024 | LLY | Buy Now | Eli Lilly and Co | $912.33 | 12.13% | $1023 → $1023 | Maintains | Overweight | Get Alert |
| 05/06/2024 | BPMC | Buy Now | Blueprint Medicines | $110.06 | 52.65% | $121 → $168 | Maintains | Buy | Get Alert |
| 05/03/2024 | AMGN | Buy Now | Amgen | $311.87 | -0.6% | $271 → $310 | Maintains | Equal-Weight | Get Alert |
| 05/02/2024 | PFE | Buy Now | Pfizer | $27.98 | 3.65% | $28 → $29 | Maintains | Equal-Weight | Get Alert |
| 04/17/2024 | JNJ | Buy Now | Johnson & Johnson | $145.64 | 14.66% | $168 → $167 | Maintains | Equal-Weight | Get Alert |
| 02/26/2024 | NRIX | Buy Now | Nurix Therapeutics | $19.30 | -48.19% | $9 → $10 | Maintains | Equal-Weight | Get Alert |
| 02/26/2024 | CRSP | Buy Now | CRISPR Therapeutics | $52.56 | -8.68% | $46 → $48 | Maintains | Underweight | Get Alert |
| 02/26/2024 | CCCC | Buy Now | C4 Therapeutics | $4.47 | 78.97% | $1 → $8 | Maintains | Equal-Weight | Get Alert |
| 02/16/2024 | LLY | Buy Now | Eli Lilly | $912.33 | 4.13% | $805 → $950 | Maintains | Overweight | Get Alert |
| 02/07/2024 | AMGN | Buy Now | Amgen | $311.87 | -10.86% | $281 → $278 | Maintains | Equal-Weight | Get Alert |
| 01/24/2024 | JNJ | Buy Now | Johnson & Johnson | $145.64 | 16.04% | $170 → $169 | Maintains | Equal-Weight | Get Alert |
| 11/13/2023 | RCUS | Buy Now | Arcus Biosciences | $13.73 | 154.92% | $38 → $35 | Maintains | Overweight | Get Alert |
| 11/13/2023 | ARVN | Buy Now | Arvinas | $23.90 | -16.32% | $32 → $20 | Maintains | Equal-Weight | Get Alert |
| 11/13/2023 | CRSP | Buy Now | CRISPR Therapeutics | $52.56 | -20.1% | $43 → $42 | Maintains | Underweight | Get Alert |
| 11/13/2023 | NTLA | Buy Now | Intellia Therapeutics | $22.84 | 272.15% | $90 → $85 | Maintains | Overweight | Get Alert |
| 11/09/2023 | RPRX | Buy Now | Royalty Pharma | $25.57 | 122.92% | $54 → $57 | Maintains | Overweight | Get Alert |
| 11/06/2023 | CCCC | Buy Now | C4 Therapeutics | $4.47 | -77.63% | $3 → $1 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 11/02/2023 | UTHR | Buy Now | United Therapeutics | $311.04 | 0.95% | $318 → $314 | Maintains | Overweight | Get Alert |
| 11/01/2023 | PFE | Buy Now | Pfizer | $27.98 | 32.24% | $39 → $37 | Maintains | Equal-Weight | Get Alert |
| 11/01/2023 | AMGN | Buy Now | Amgen | $311.87 | -6.69% | $300 → $291 | Maintains | Equal-Weight | Get Alert |
| 10/30/2023 | ABBV | Buy Now | AbbVie | $165.93 | 18.12% | $193 → $196 | Maintains | Overweight | Get Alert |
| 10/27/2023 | MRK | Buy Now | Merck & Co | $126.31 | -6.58% | $115 → $118 | Maintains | Equal-Weight | Get Alert |
| 10/27/2023 | BMY | Buy Now | Bristol-Myers Squibb | $39.54 | 26.45% | $56 → $50 | Maintains | Underweight | Get Alert |
| 10/18/2023 | JNJ | Buy Now | Johnson & Johnson | $145.64 | 17.41% | $174 → $171 | Maintains | Equal-Weight | Get Alert |
| 10/17/2023 | PFE | Buy Now | Pfizer | $27.98 | 39.39% | $40 → $39 | Maintains | Equal-Weight | Get Alert |
| 10/17/2023 | AMGN | Buy Now | Amgen | $311.87 | -3.8% | → $300 | Reinstates | → Equal-Weight | Get Alert |
| 10/11/2023 | RPRX | Buy Now | Royalty Pharma | $25.57 | 111.18% | $53 → $54 | Maintains | Overweight | Get Alert |
| 10/11/2023 | RVNC | Buy Now | Revance Therapeutics | $2.65 | 352.83% | $25 → $12 | Maintains | Equal-Weight | Get Alert |
| 10/11/2023 | OGN | Buy Now | Organon | $20.06 | 9.67% | $27 → $22 | Maintains | Equal-Weight | Get Alert |
| 10/11/2023 | MRK | Buy Now | Merck & Co | $126.31 | -8.95% | $116 → $115 | Maintains | Equal-Weight | Get Alert |
| 10/11/2023 | JNJ | Buy Now | Johnson & Johnson | $145.64 | 19.47% | $172 → $174 | Maintains | Equal-Weight | Get Alert |
| 10/11/2023 | BMY | Buy Now | Bristol-Myers Squibb | $39.54 | 41.63% | $57 → $56 | Maintains | Underweight | Get Alert |
| 10/11/2023 | ABBV | Buy Now | AbbVie | $165.93 | 16.31% | $189 → $193 | Maintains | Overweight | Get Alert |
| 08/31/2023 | JNJ | Buy Now | Johnson & Johnson | $145.64 | 18.1% | $187 → $172 | Maintains | Equal-Weight | Get Alert |
| 08/14/2023 | CRSP | Buy Now | CRISPR Therapeutics | $52.56 | -18.2% | $42 → $43 | Maintains | Underweight | Get Alert |
| 08/14/2023 | ARVN | Buy Now | Arvinas | $23.90 | 33.89% | $35 → $32 | Maintains | Equal-Weight | Get Alert |
| 08/09/2023 | RPRX | Buy Now | Royalty Pharma | $25.57 | 107.27% | $52 → $53 | Maintains | Overweight | Get Alert |
| 08/09/2023 | RVNC | Buy Now | Revance Therapeutics | $2.65 | 843.4% | $26 → $25 | Maintains | Equal-Weight | Get Alert |
| 08/09/2023 | OGN | Buy Now | Organon | $20.06 | 34.6% | $25 → $27 | Maintains | Equal-Weight | Get Alert |
| 08/08/2023 | RCUS | Buy Now | Arcus Biosciences | $13.73 | 176.77% | $40 → $38 | Maintains | Overweight | Get Alert |
| 08/03/2023 | UTHR | Buy Now | United Therapeutics | $311.04 | 2.24% | $316 → $318 | Maintains | Overweight | Get Alert |
| 08/03/2023 | BPMC | Buy Now | Blueprint Medicines | $110.06 | -24.58% | $93 → $83 | Maintains | Buy | Get Alert |
| 08/02/2023 | PFE | Buy Now | Pfizer | $27.98 | 42.96% | $42 → $40 | Maintains | Equal-Weight | Get Alert |
| 08/02/2023 | MRK | Buy Now | Merck & Co | $126.31 | -8.16% | $109 → $116 | Maintains | Equal-Weight | Get Alert |
| 07/21/2023 | JNJ | Buy Now | Johnson & Johnson | $145.64 | 28.4% | $187 → $187 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/21/2023 | PFE | Buy Now | Pfizer | $27.98 | 50.11% | $43 → $42 | Maintains | Equal-Weight | Get Alert |
| 07/19/2023 | BMY | Buy Now | Bristol-Myers Squibb | $39.54 | 49.22% | $59 → $59 | Reiterates | Underweight → Underweight | Get Alert |
| 07/17/2023 | NRIX | Buy Now | Nurix Therapeutics | $19.30 | -37.82% | $11 → $12 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | RPRX | Buy Now | Royalty Pharma | $25.57 | 103.36% | $52 → $52 | Reiterates | Overweight → Overweight | Get Alert |
| 07/11/2023 | RVNC | Buy Now | Revance Therapeutics | $2.65 | 881.13% | $26 → $26 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/11/2023 | PFE | Buy Now | Pfizer | $27.98 | 53.68% | $43 → $43 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/11/2023 | MRK | Buy Now | Merck & Co | $126.31 | -13.7% | $109 → $109 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/11/2023 | JNJ | Buy Now | Johnson & Johnson | $145.64 | 28.4% | $183 → $187 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | BMY | Buy Now | Bristol-Myers Squibb | $39.54 | 49.22% | $59 → $59 | Reiterates | Underweight → Underweight | Get Alert |
| 07/11/2023 | ABBV | Buy Now | AbbVie | $165.93 | 9.68% | $182 → $182 | Reiterates | Overweight → Overweight | Get Alert |
| 05/12/2023 | CRSP | Buy Now | CRISPR Therapeutics | $52.56 | -20.1% | $39 → $42 | Maintains | Underweight | Get Alert |
| 05/12/2023 | CCCC | Buy Now | C4 Therapeutics | $4.47 | -32.89% | $5 → $3 | Maintains | Underweight | Get Alert |
| 05/12/2023 | ARVN | Buy Now | Arvinas | $23.90 | 46.44% | $38 → $35 | Maintains | Equal-Weight | Get Alert |
| 05/10/2023 | RPRX | Buy Now | Royalty Pharma | $25.57 | 103.36% | $50 → $52 | Maintains | Overweight | Get Alert |
| 05/08/2023 | OGN | Buy Now | Organon | $20.06 | 24.63% | $26 → $25 | Maintains | Equal-Weight | Get Alert |
| 05/08/2023 | NTLA | Buy Now | Intellia Therapeutics | $22.84 | 276.53% | $83 → $86 | Maintains | Overweight | Get Alert |
| 04/28/2023 | ABBV | Buy Now | AbbVie | $165.93 | 9.68% | $181 → $182 | Maintains | Overweight | Get Alert |
| 04/19/2023 | JNJ | Buy Now | Johnson & Johnson | $145.64 | 25.65% | $179 → $183 | Maintains | Equal-Weight | Get Alert |
| 04/10/2023 | UTHR | Buy Now | United Therapeutics | $311.04 | 1.59% | $320 → $316 | Maintains | Overweight | Get Alert |
| 04/10/2023 | RPRX | Buy Now | Royalty Pharma | $25.57 | 95.54% | $48 → $50 | Maintains | Overweight | Get Alert |
| 04/10/2023 | PFE | Buy Now | Pfizer | $27.98 | 57.26% | $45 → $44 | Maintains | Equal-Weight | Get Alert |
| 04/10/2023 | JNJ | Buy Now | Johnson & Johnson | $145.64 | 22.9% | $180 → $179 | Maintains | Equal-Weight | Get Alert |
| 04/10/2023 | LLY | Buy Now | Eli Lilly | $912.33 | -50.89% | $444 → $448 | Maintains | Overweight | Get Alert |
| 04/10/2023 | ABBV | Buy Now | AbbVie | $165.93 | 9.08% | $178 → $181 | Maintains | Overweight | Get Alert |
| 03/01/2023 | LLY | Buy Now | Eli Lilly | $912.33 | -51.33% | $455 → $444 | Maintains | Overweight | Get Alert |
| 02/27/2023 | CRSP | Buy Now | CRISPR Therapeutics | $52.56 | -25.81% | $37 → $39 | Maintains | Underweight | Get Alert |
| 02/27/2023 | CCCC | Buy Now | C4 Therapeutics | $4.47 | 11.86% | $6 → $5 | Maintains | Underweight | Get Alert |
| 02/27/2023 | ARVN | Buy Now | Arvinas | $23.90 | 50.63% | $57 → $36 | Maintains | Equal-Weight | Get Alert |
| 02/23/2023 | UTHR | Buy Now | United Therapeutics | $311.04 | 2.88% | $330 → $320 | Maintains | Overweight | Get Alert |
| 02/10/2023 | ABBV | Buy Now | AbbVie | $165.93 | 7.27% | $182 → $178 | Maintains | Overweight | Get Alert |
| 02/03/2023 | MRK | Buy Now | Merck & Co | $126.31 | -21.62% | $100 → $99 | Maintains | Equal-Weight | Get Alert |
| 02/03/2023 | LLY | Buy Now | Eli Lilly | $912.33 | -50.13% | $440 → $455 | Maintains | Overweight | Get Alert |
| 02/03/2023 | BMY | Buy Now | Bristol-Myers Squibb | $39.54 | 56.8% | $60 → $62 | Maintains | Underweight | Get Alert |
| 02/01/2023 | PFE | Buy Now | Pfizer | $27.98 | 60.83% | $53 → $45 | Maintains | Equal-Weight | Get Alert |
| 01/25/2023 | JNJ | Buy Now | Johnson & Johnson | $145.64 | 23.59% | $176 → $180 | Maintains | Equal-Weight | Get Alert |
| 01/24/2023 | RVNC | Buy Now | Revance Therapeutics | $2.65 | 881.13% | $25 → $26 | Maintains | Equal-Weight | Get Alert |
| 12/14/2022 | PFE | Buy Now | Pfizer | $27.98 | 89.42% | $51 → $53 | Maintains | Equal-Weight | Get Alert |
| 12/14/2022 | LLY | Buy Now | Eli Lilly | $912.33 | -51.77% | $446 → $440 | Maintains | Overweight | Get Alert |
| 12/06/2022 | UTHR | Buy Now | United Therapeutics | $311.04 | 6.1% | $322 → $330 | Maintains | Overweight | Get Alert |
| 12/06/2022 | RPRX | Buy Now | Royalty Pharma | $25.57 | 99.45% | $54 → $51 | Maintains | Overweight | Get Alert |
| 12/06/2022 | JNJ | Buy Now | Johnson & Johnson | $145.64 | 20.84% | $178 → $176 | Maintains | Equal-Weight | Get Alert |
| 12/06/2022 | LLY | Buy Now | Eli Lilly | $912.33 | -51.11% | $436 → $446 | Maintains | Overweight | Get Alert |
| 12/01/2022 | JNJ | Buy Now | Johnson & Johnson | $145.64 | 22.22% | $170 → $178 | Maintains | Equal-Weight | Get Alert |
| 11/17/2022 | LLY | Buy Now | Eli Lilly | $912.33 | -52.21% | $441 → $436 | Maintains | Overweight | Get Alert |
| 11/11/2022 | ARVN | Buy Now | Arvinas | $23.90 | 138.49% | $63 → $57 | Maintains | Equal-Weight | Get Alert |
| 11/09/2022 | RPRX | Buy Now | Royalty Pharma | $25.57 | 111.18% | $51 → $54 | Maintains | Overweight | Get Alert |
| 11/09/2022 | RVNC | Buy Now | Revance Therapeutics | $2.65 | 843.4% | $27 → $25 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | OGN | Buy Now | Organon | $20.06 | 19.64% | $27 → $24 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | NTLA | Buy Now | Intellia Therapeutics | $22.84 | 263.4% | $84 → $83 | Maintains | Overweight | Get Alert |
| 11/03/2022 | BPMC | Buy Now | Blueprint Medicines | $110.06 | -1.87% | $143 → $108 | Maintains | Buy | Get Alert |
| 11/03/2022 | UTHR | Buy Now | United Therapeutics | $311.04 | 3.52% | $288 → $322 | Maintains | Overweight | Get Alert |
| 11/02/2022 | PFE | Buy Now | Pfizer | $27.98 | 82.27% | $50 → $51 | Maintains | Equal-Weight | Get Alert |
| 11/02/2022 | LLY | Buy Now | Eli Lilly | $912.33 | -51.66% | $408 → $441 | Maintains | Overweight | Get Alert |
| 10/28/2022 | MRK | Buy Now | Merck & Co | $126.31 | -20.83% | $91 → $100 | Maintains | Equal-Weight | Get Alert |
| 10/27/2022 | BMY | Buy Now | Bristol-Myers Squibb | $39.54 | 51.75% | $61 → $60 | Maintains | Underweight | Get Alert |
| 10/19/2022 | JNJ | Buy Now | Johnson & Johnson | $145.64 | 16.72% | $174 → $170 | Maintains | Equal-Weight | Get Alert |
| 10/12/2022 | OGN | Buy Now | Organon | $20.06 | 34.6% | $35 → $27 | Maintains | Equal-Weight | Get Alert |
| 10/12/2022 | MRK | Buy Now | Merck & Co | $126.31 | -27.96% | $92 → $91 | Maintains | Equal-Weight | Get Alert |
| 10/12/2022 | JNJ | Buy Now | Johnson & Johnson | $145.64 | 19.47% | $173 → $174 | Maintains | Equal-Weight | Get Alert |
| 10/12/2022 | LLY | Buy Now | Eli Lilly | $912.33 | -55.28% | $412 → $408 | Maintains | Overweight | Get Alert |
| 10/12/2022 | PFE | Buy Now | Pfizer | $27.98 | 78.7% | $49 → $50 | Maintains | Equal-Weight | Get Alert |
| 10/11/2022 | NRIX | Buy Now | Nurix Therapeutics | $19.30 | -43.01% | → $11 | Initiates | → Equal-Weight | Get Alert |
| 10/11/2022 | NTLA | Buy Now | Intellia Therapeutics | $22.84 | 267.78% | → $84 | Initiates | → Overweight | Get Alert |
| 10/11/2022 | UTHR | Buy Now | United Therapeutics | $311.04 | -7.41% | → $288 | Initiates | → Overweight | Get Alert |
| 10/11/2022 | RCUS | Buy Now | Arcus Biosciences | $13.73 | 191.33% | → $40 | Initiates | → Overweight | Get Alert |
| 10/11/2022 | CRSP | Buy Now | CRISPR Therapeutics | $52.56 | -29.61% | → $37 | Initiates | → Underweight | Get Alert |
| 10/11/2022 | CCCC | Buy Now | C4 Therapeutics | $4.47 | 34.23% | → $6 | Initiates | → Underweight | Get Alert |
| 10/11/2022 | RVNC | Buy Now | Revance Therapeutics | $2.65 | 918.87% | → $27 | Initiates | → Equal-Weight | Get Alert |
| 09/14/2022 | ABBV | Buy Now | AbbVie | $165.93 | 13.3% | → $188 | Reiterates | → Overweight | Get Alert |
| 09/12/2022 | JNJ | Buy Now | Johnson & Johnson | $145.64 | 18.78% | $174 → $173 | Maintains | Equal-Weight | Get Alert |
| 09/07/2022 | LLY | Buy Now | Eli Lilly | $912.33 | -54.84% | $395 → $412 | Maintains | Overweight | Get Alert |
| 08/08/2022 | RPRX | Buy Now | Royalty Pharma | $25.57 | 99.45% | $48 → $51 | Maintains | Overweight | Get Alert |
| 08/03/2022 | BPMC | Buy Now | Blueprint Medicines | $110.06 | 29.94% | $126 → $143 | Maintains | Buy | Get Alert |
| 07/29/2022 | MRK | Buy Now | Merck & Co | $126.31 | -27.16% | $88 → $92 | Maintains | Equal-Weight | Get Alert |
| 07/28/2022 | BMY | Buy Now | Bristol-Myers Squibb | $39.54 | 54.27% | $63 → $61 | Maintains | Underweight | Get Alert |
| 07/08/2022 | PFE | Buy Now | Pfizer | $27.98 | 75.13% | $52 → $49 | Maintains | Equal-Weight | Get Alert |
| 07/08/2022 | OGN | Buy Now | Organon | $20.06 | 69.49% | $35 → $34 | Maintains | Equal-Weight | Get Alert |
| 07/08/2022 | MRK | Buy Now | Merck & Co | $126.31 | -30.33% | $87 → $88 | Maintains | Equal-Weight | Get Alert |
| 07/08/2022 | JNJ | Buy Now | Johnson & Johnson | $145.64 | 19.47% | $173 → $174 | Maintains | Equal-Weight | Get Alert |
| 07/08/2022 | LLY | Buy Now | Eli Lilly | $912.33 | -56.7% | $369 → $395 | Maintains | Overweight | Get Alert |
| 07/08/2022 | ABBV | Buy Now | AbbVie | $165.93 | 15.11% | $188 → $191 | Maintains | Overweight | Get Alert |
| 05/09/2022 | ARVN | Buy Now | Arvinas | $23.90 | 167.78% | $65 → $64 | Maintains | Equal-Weight | Get Alert |
| 05/02/2022 | BMY | Buy Now | Bristol-Myers Squibb | $39.54 | 59.33% | $64 → $63 | Maintains | Underweight | Get Alert |
| 04/29/2022 | MRK | Buy Now | Merck & Co | $126.31 | -31.12% | $80 → $87 | Maintains | Equal-Weight | Get Alert |
| 04/29/2022 | LLY | Buy Now | Eli Lilly | $912.33 | -59.55% | $364 → $369 | Maintains | Overweight | Get Alert |
| 04/06/2022 | OGN | Buy Now | Organon | $20.06 | 74.48% | $37 → $35 | Maintains | Equal-Weight | Get Alert |
| 04/06/2022 | MRK | Buy Now | Merck & Co | $126.31 | -36.66% | $82 → $80 | Maintains | Equal-Weight | Get Alert |
| 04/06/2022 | LLY | Buy Now | Eli Lilly | $912.33 | -60.1% | $265 → $364 | Maintains | Overweight | Get Alert |
| 04/06/2022 | ABBV | Buy Now | AbbVie | $165.93 | 15.71% | $142 → $192 | Maintains | Overweight | Get Alert |
| 04/06/2022 | RPRX | Buy Now | Royalty Pharma | $25.57 | 87.72% | $46 → $48 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/06/2022 | BMY | Buy Now | Bristol-Myers Squibb | $39.54 | 61.86% | $66 → $64 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 04/06/2022 | ARVN | Buy Now | Arvinas | $23.90 | 171.97% | → $65 | Initiates | → Equal-Weight | Get Alert |
| 10/05/2020 | TBIO | Buy Now | Telesis Bio | $3.56 | 433.71% | → $342 | Initiates | → Buy | Get Alert |
